Chitosan gel barrier (null)

Chitosan gel barrier refers to a semisolid or hydrogel formulation made from chitosan, a linear polysaccharide derived from chitin, commonly obtained from crustacean shells.[1][2][3][4] These hydrogels are biocompatible, biodegradable, exhibit antibacterial and antifungal properties, and possess bioadhesive and antioxidant activities.[1][2][4] Chitosan gels are chiefly used as barrier biomaterials—meaning they act as physical barriers to prevent adhesions in surgery, facilitate wound healing, and serve as scaffolds in tissue engineering.[1][3] They can also be loaded with drugs, growth factors, or cells for drug delivery and regenerative medicine applications, enhancing local therapeutic efficacy and minimizing systemic side effects.[2][3] Importantly, chitosan gel barrier is not a discrete molecular therapeutic target (such as a receptor, enzyme, channel, or transporter) but instead is a biomaterial used for its barrier, scaffold, and carrier properties.[3][4] Therefore, it does not have a canonical molecular abbreviation nor is it a pharmacological target as conventionally defined.[1][2][3][4] Summary of issue: "Chitosan gel barrier" is not a molecular therapeutic target; it is a material class (hydrogel biomaterial) used in biomedical applications for its biocompatible, antibacterial, and tissue-regenerating properties. It is not a receptor, enzyme, transporter, or analogous druggable target.[1][2][3][4]

Other names

Chitosan hydrogel barrierChitosan-based hydrogel

Acts as a mucoadhesive delivery vehicle; Provides a scaffold for cell proliferation; Physical barrier to microbial invasion; Sustained, localized drug release[2][3]